Nemosia AG

The missing link in the fight against neurodegeneration!

At Nemosia, we aim to raise public awareness of neurological disorders and promote a culture where it is seen as normal and safe to do regular brain check-ups even if there are no visible symptoms.
We are developing radiotracers for early diagnostic of neurodegenerative diseases such as multiple sclerosis and Alzheimer's disease.
This diagnosis is performed using PET imaging to visualize receptors inside the brain.

We see Nemosia as the missing piece to support drug development, therapy monitoring patient recruitment and early detection.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2021

Website

Venture Leaders Biotech

Venture Leaders Biotech 2021

Nemosia AG

The missing link in the fight against neurodegeneration!

Website:
www.nemosia.com

Headquarter:
Winterthur

Foundation Date:
September 2022

Technology:

  • Medtech

Sectors:

  • Biotech
  • Diagnostics
  • Drug discovery
  • Imaging and Radiology
  • Medtech
  • Small molecule drugs

Support received

  • Support venture leaders
  • Support venturekick